Status:
RECRUITING
The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborating Sponsors:
Binding site
Conditions:
Polyclonal Hypergammaglobulinemia
Autoimmune Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Polyclonal hypergammaglobulinaemia is characterized by increased levels of immunoglobulins and is a common feature observed in various diseases such as autoimmune diseases, chronic infectious diseases...
Eligibility Criteria
Inclusion
- All adult patients \> 18 years old
- patients with one of the following diseases: systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, autoimmune hepatitis, sarcoidosis or lymphoma.
Exclusion
- Age \< 18 years;
- chronic viral hepatitis;
- HIV infection, syphilis,
- tuberculosis
Key Trial Info
Start Date :
July 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06054373
Start Date
July 27 2023
End Date
September 1 2024
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80054